...
首页> 外文期刊>The FEBS journal >Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease - FEBS anniversary prize lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw
【24h】

Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease - FEBS anniversary prize lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw

机译:自然,养育和神经病学:神经退行性疾病中的基因-环境相互作用-2004年6月27日在华沙第29届FEBS大会上发表的FEBS周年纪念奖演讲

获取原文
获取原文并翻译 | 示例
           

摘要

Neurodegenerative disorders, such as Huntington's, Alzheimer's, and Parkinson's diseases, affect millions of people worldwide and currently there are few effective treatments and no cures for these diseases. Transgenic mice expressing human transgenes for huntingtin, amyloid precursor protein, and other genes associated with familial forms of neurodegenerative disease in humans provide remarkable tools for studying neurodegeneration because they mimic many of the pathological and behavioural features of the human conditions. One of the recurring themes revealed by these various transgenic models is that different diseases may share similar molecular and cellular mechanisms of pathogenesis. Cellular mechanisms known to be disrupted at early stages in multiple neurodegenerative disorders include gene expression, protein interactions (manifesting as pathological protein aggregation and disrupted signaling), synaptic function and plasticity. Recent work in mouse models of Huntington's disease has shown that enriching the environment of transgenic animals delays the onset and slows the progression of Huntington's disease-associated motor and cognitive symptoms. Environmental enrichment is known to induce various molecular and cellular changes in specific brain regions of wild-type animals, including altered gene expression profiles, enhanced neurogenesis and synaptic plasticity. The promising effects of environmental stimulation, demonstrated recently in models of neurodegenerative disease, suggest that therapy based on the principles of environmental enrichment might benefit disease sufferers and provide insight into possible mechanisms of neurodegeneration and subsequent identification of novel therapeutic targets. Here, we review the studies of environmental enrichment relevant to some major neurodegenerative diseases and discuss their research and clinical implications.
机译:神经退行性疾病,例如亨廷顿氏病,阿尔茨海默氏病和帕金森氏病,影响着全球数百万人,目前尚无有效的治疗方法,也无法治愈这些疾病。表达人类亨廷顿蛋白,淀粉样蛋白前体蛋白以及与人类神经退行性疾病的家族形式相关的其他基因的人类转基因的转基因小鼠为研究神经变性提供了卓越的工具,因为它们模仿了人类疾病的许多病理和行为特征。这些各种转基因模型揭示的重复主题之一是,不同的疾病可能共享相似的发病机理分子和细胞机制。已知在多种神经退行性疾病的早期被破坏的细胞机制包括基因表达,蛋白质相互作用(表现为病理性蛋白质聚集和信号传导中断),突触功能和可塑性。亨廷顿氏病小鼠模型的最新研究表明,丰富转基因动物的环境可延缓其发作,并减慢亨廷顿氏病相关的运动和认知症状的进展。已知环境富集会在野生型动物的特定大脑区域诱发各种分子和细胞变化,包括基因表达谱改变,神经发生增强和突触可塑性。最近在神经退行性疾病模型中证明的环境刺激的有希望的效果表明,基于环境富集原理的疗法可能使疾病患者受益,并为神经退行性变的可能机制和新的治疗靶标的鉴定提供了见识。在这里,我们审查与一些主要的神经退行性疾病有关的环境富集的研究,并讨论它们的研究和临床意义。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号